Similarity of ventricular function in patients alive 5 years after randomization to surgery or angioplasty in the BARI trial

Raymond J. Gibbons, Donald D Miller, Peter Liu, Ping Guo, Maria Mori Brooks, Markus Schwaiger

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background - Left ventricular ejection fraction (LVEF) is a recognized determinant of survival in patients with coronary artery disease. In major trials comparing surgical and percutaneous revascularization approaches, the long-term effect of the coronary revascularization strategy on LVEF has not been reported. Methods and Results - In the NHLBI-sponsored Bypass and Angioplasty Revascularization Investigation (BARI) randomized trial comparing angioplasty and bypass surgery as initial treatment strategies, 1220 (75%) of the 1617 surviving randomized patients had their EF measured by radionuclide ventriculography 5 years after study entry. For the total study group, the 5-year EF in the CABG group (n=623) was 55.8±12.3, compared with 55.7±12.7 in PTCA group (n=597, P=0.82). There was no significant difference in measured EF between the CABG group and the PTCA group within multiple subgroups determined by the presence or absence of diabetes, 3-vessel disease, complete revascularization, or prior myocardial infarction. In a multiple linear regression model developed to predict 5-year EF, treatment assignment to PTCA or CABG was not significant (P=0.95). If an EF of 0 was imputed for patients who were dead and missing EF data, however, there was a higher EF in the CABG group (P=0.0018) among diabetic patients only. Conclusions - In the BARI randomized trial, initial treatment assignment to angioplasty was not associated with any difference in long-term ventricular function compared with initial treatment assignment to surgery. These results apply, however, only to patients who were alive at 5 years.

Original languageEnglish (US)
Pages (from-to)1076-1082
Number of pages7
JournalCirculation
Volume103
Issue number8
DOIs
StatePublished - Feb 27 2001

Fingerprint

Ventricular Function
Random Allocation
Angioplasty
Stroke Volume
Linear Models
Radionuclide Ventriculography
National Heart, Lung, and Blood Institute (U.S.)
Therapeutics
Coronary Artery Disease
Myocardial Infarction
Survival

Keywords

  • Angioplasty
  • Bypass
  • Coronary disease
  • Ventricles

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Similarity of ventricular function in patients alive 5 years after randomization to surgery or angioplasty in the BARI trial. / Gibbons, Raymond J.; Miller, Donald D; Liu, Peter; Guo, Ping; Brooks, Maria Mori; Schwaiger, Markus.

In: Circulation, Vol. 103, No. 8, 27.02.2001, p. 1076-1082.

Research output: Contribution to journalArticle

Gibbons, Raymond J. ; Miller, Donald D ; Liu, Peter ; Guo, Ping ; Brooks, Maria Mori ; Schwaiger, Markus. / Similarity of ventricular function in patients alive 5 years after randomization to surgery or angioplasty in the BARI trial. In: Circulation. 2001 ; Vol. 103, No. 8. pp. 1076-1082.
@article{434c9525d69a4fa2b56bdb3303d5e004,
title = "Similarity of ventricular function in patients alive 5 years after randomization to surgery or angioplasty in the BARI trial",
abstract = "Background - Left ventricular ejection fraction (LVEF) is a recognized determinant of survival in patients with coronary artery disease. In major trials comparing surgical and percutaneous revascularization approaches, the long-term effect of the coronary revascularization strategy on LVEF has not been reported. Methods and Results - In the NHLBI-sponsored Bypass and Angioplasty Revascularization Investigation (BARI) randomized trial comparing angioplasty and bypass surgery as initial treatment strategies, 1220 (75{\%}) of the 1617 surviving randomized patients had their EF measured by radionuclide ventriculography 5 years after study entry. For the total study group, the 5-year EF in the CABG group (n=623) was 55.8±12.3, compared with 55.7±12.7 in PTCA group (n=597, P=0.82). There was no significant difference in measured EF between the CABG group and the PTCA group within multiple subgroups determined by the presence or absence of diabetes, 3-vessel disease, complete revascularization, or prior myocardial infarction. In a multiple linear regression model developed to predict 5-year EF, treatment assignment to PTCA or CABG was not significant (P=0.95). If an EF of 0 was imputed for patients who were dead and missing EF data, however, there was a higher EF in the CABG group (P=0.0018) among diabetic patients only. Conclusions - In the BARI randomized trial, initial treatment assignment to angioplasty was not associated with any difference in long-term ventricular function compared with initial treatment assignment to surgery. These results apply, however, only to patients who were alive at 5 years.",
keywords = "Angioplasty, Bypass, Coronary disease, Ventricles",
author = "Gibbons, {Raymond J.} and Miller, {Donald D} and Peter Liu and Ping Guo and Brooks, {Maria Mori} and Markus Schwaiger",
year = "2001",
month = "2",
day = "27",
doi = "10.1161/01.CIR.103.8.1076",
language = "English (US)",
volume = "103",
pages = "1076--1082",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Similarity of ventricular function in patients alive 5 years after randomization to surgery or angioplasty in the BARI trial

AU - Gibbons, Raymond J.

AU - Miller, Donald D

AU - Liu, Peter

AU - Guo, Ping

AU - Brooks, Maria Mori

AU - Schwaiger, Markus

PY - 2001/2/27

Y1 - 2001/2/27

N2 - Background - Left ventricular ejection fraction (LVEF) is a recognized determinant of survival in patients with coronary artery disease. In major trials comparing surgical and percutaneous revascularization approaches, the long-term effect of the coronary revascularization strategy on LVEF has not been reported. Methods and Results - In the NHLBI-sponsored Bypass and Angioplasty Revascularization Investigation (BARI) randomized trial comparing angioplasty and bypass surgery as initial treatment strategies, 1220 (75%) of the 1617 surviving randomized patients had their EF measured by radionuclide ventriculography 5 years after study entry. For the total study group, the 5-year EF in the CABG group (n=623) was 55.8±12.3, compared with 55.7±12.7 in PTCA group (n=597, P=0.82). There was no significant difference in measured EF between the CABG group and the PTCA group within multiple subgroups determined by the presence or absence of diabetes, 3-vessel disease, complete revascularization, or prior myocardial infarction. In a multiple linear regression model developed to predict 5-year EF, treatment assignment to PTCA or CABG was not significant (P=0.95). If an EF of 0 was imputed for patients who were dead and missing EF data, however, there was a higher EF in the CABG group (P=0.0018) among diabetic patients only. Conclusions - In the BARI randomized trial, initial treatment assignment to angioplasty was not associated with any difference in long-term ventricular function compared with initial treatment assignment to surgery. These results apply, however, only to patients who were alive at 5 years.

AB - Background - Left ventricular ejection fraction (LVEF) is a recognized determinant of survival in patients with coronary artery disease. In major trials comparing surgical and percutaneous revascularization approaches, the long-term effect of the coronary revascularization strategy on LVEF has not been reported. Methods and Results - In the NHLBI-sponsored Bypass and Angioplasty Revascularization Investigation (BARI) randomized trial comparing angioplasty and bypass surgery as initial treatment strategies, 1220 (75%) of the 1617 surviving randomized patients had their EF measured by radionuclide ventriculography 5 years after study entry. For the total study group, the 5-year EF in the CABG group (n=623) was 55.8±12.3, compared with 55.7±12.7 in PTCA group (n=597, P=0.82). There was no significant difference in measured EF between the CABG group and the PTCA group within multiple subgroups determined by the presence or absence of diabetes, 3-vessel disease, complete revascularization, or prior myocardial infarction. In a multiple linear regression model developed to predict 5-year EF, treatment assignment to PTCA or CABG was not significant (P=0.95). If an EF of 0 was imputed for patients who were dead and missing EF data, however, there was a higher EF in the CABG group (P=0.0018) among diabetic patients only. Conclusions - In the BARI randomized trial, initial treatment assignment to angioplasty was not associated with any difference in long-term ventricular function compared with initial treatment assignment to surgery. These results apply, however, only to patients who were alive at 5 years.

KW - Angioplasty

KW - Bypass

KW - Coronary disease

KW - Ventricles

UR - http://www.scopus.com/inward/record.url?scp=0035957022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035957022&partnerID=8YFLogxK

U2 - 10.1161/01.CIR.103.8.1076

DO - 10.1161/01.CIR.103.8.1076

M3 - Article

C2 - 11222469

AN - SCOPUS:0035957022

VL - 103

SP - 1076

EP - 1082

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 8

ER -